Mardi C Dier's Insider Trades & SAST Disclosures
Mardi C Dier's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 258 Common Stock done at an average price of $323.0 . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mardi C Dier.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 323.04 per share. | 10 Mar 2025 | 258 | 10,440 (0%) | 0% | 323.0 | 83,344 | Common Stock |
| Madrigal Pharmaceuticals Inc | Mardi C. Dier | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 6,374 | 6,374 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Mardi C. Dier | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 3,784 | 10,698 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 325.89 per share. | 03 Mar 2025 | 1,187 | 7,688 (0%) | 0% | 325.9 | 386,831 | Common Stock |
| Madrigal Pharmaceuticals Inc | Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 323.54 per share. | 03 Mar 2025 | 774 | 6,914 (0%) | 0% | 323.5 | 250,417 | Common Stock |
| ORIC Pharmaceuticals Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| ORIC Pharmaceuticals Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 25,600 | 25,600 | - | - | Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| ORIC Pharmaceuticals Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 673,621 | 0 | - | - | Employee Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 673,621 | 673,621 | - | - | Employee Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 85,226 | 85,226 | - | - | Employee Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 85,226 | 0 | - | - | Employee Stock Option (right to buy) | |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 May 2023 | 5,556 | 5,556 | - | 18 | 100,008 | Common Stock |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 May 2023 | 875 | 875 | - | 18 | 15,750 | Common Stock |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 May 2023 | 875 | 875 | - | 18 | 15,750 | Common Stock |
| Acelyrin Inc | Mardi C. Dier | CFO and CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 85,226 | 85,226 | - | - | Employee Stock Option (right to buy) | |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 40.16 per share. | 14 Oct 2022 | 1,629 | 66,695 (0%) | 0% | 40.2 | 65,421 | Common Stock |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 12 Oct 2022 | 3,484 | 68,324 (0%) | 0% | 38.2 | 133,158 | Common Stock |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2022 | 20,000 | 71,808 (0%) | 0% | 0 | Common Stock | |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 34,300 | 34,300 | - | - | Director Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 24,900 | 24,900 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 14,000 | 52,228 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 66.62 per share. | 01 Mar 2022 | 534 | 38,228 (0%) | 0% | 66.6 | 35,575 | Common Stock |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 64.55 per share. | 01 Mar 2022 | 420 | 51,808 (0%) | 0% | 64.6 | 27,111 | Common Stock |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 82.79 per share. | 12 Oct 2021 | 3,477 | 42,023 (0%) | 0% | 82.8 | 287,861 | Common Stock |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Sale of securities on an exchange or to another person at price $ 81.16 per share. | 12 Oct 2021 | 3,261 | 38,762 (0%) | 0% | 81.2 | 264,663 | Common Stock |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 23,344 | 23,344 | - | - | Director Stock Option (Right to Buy) | |
| ORIC Pharmaceuticals Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 16,625 | 16,625 | - | - | Stock Option (right to buy) | |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 5,500 | 45,500 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2020 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Mardi C. Dier | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2020 | 40,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 29 Sep 2020 | 10,000 | 10,000 | - | 19 | 190,000 | Common Stock |
| Prelude Therapeutics Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 3,458 | 3,458 | - | - | Director Stock Option (right to buy) | |
| ORIC Pharmaceuticals Inc | Mardi C. Dier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 33,250 | 33,250 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges